AK Medical Holdings Limited (HKG:1789)

AK Medical Holdings Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1,079	357.23	352.17	331.22	625.83	475.61
Short-Term Investments	258.34	36.29	59.27	2.88	3.05	3.1
Trading Asset Securities	-	851.92	615.24	395.46	416.59	365.53
Cash & Short-Term Investments	1,337	1,245	1,027	729.55	1,045	844.23
Cash Growth	-12.25%	21.31%	40.73%	-30.22%	23.84%	-6.64%
Accounts Receivable	781.5	694.16	576.68	530.18	545.35	530.45
Other Receivables	-	58.61	54.9	58.06	7.35	12.87
Receivables	781.5	752.78	631.58	588.24	552.71	543.32
Inventory	470.37	459.22	488.67	595.51	402.33	423.07
Restricted Cash	-	17.67	-	-	-	-
Other Current Assets	-	224.86	31.13	61.52	64.85	123.75
Total Current Assets	2,589	2,700	2,178	1,975	2,065	1,934
Property, Plant & Equipment	690.88	699.74	683.62	574.97	435.63	382.4
Long-Term Investments	-	-	10.04	-	-	-
Goodwill	113.41	113.41	113.41	113.41	113.41	132.45
Other Intangible Assets	82.51	81.13	83.34	87.97	85.28	79.99
Long-Term Deferred Tax Assets	66.75	68.5	70.68	67.26	74.82	76.07
Other Long-Term Assets	-	-	196.26	184.6	-	-
Total Assets	3,542	3,663	3,335	3,003	2,774	2,605

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	218.95	197.11	152.1	174.92	155.17	92.77
Accrued Expenses	405.7	125.68	93.47	74.5	88.2	93.45
Current Portion of Long-Term Debt	0.95	71.96	60.45	21.39	-	-
Current Portion of Leases	3.48	4.99	12.12	14.24	13.5	10.95
Current Income Taxes Payable	18.2	19.44	24.8	17.6	22.77	51.52
Current Unearned Revenue	68.65	85.72	102.91	85.3	79.85	167.41
Other Current Liabilities	-	153.05	150.58	110.22	76.9	73.33
Total Current Liabilities	715.93	657.94	596.42	498.17	436.38	489.44
Long-Term Debt	4.74	5.22	17.67	32.26	-	-
Long-Term Leases	3.75	4.27	9.15	16.31	25.28	30.61
Long-Term Unearned Revenue	17.61	18.89	19.64	10.43	13.33	12.35
Long-Term Deferred Tax Liabilities	38.48	56.14	48.54	48.03	47.41	41.34
Other Long-Term Liabilities	7.5	7.37	5.8	5.93	8.32	-
Total Liabilities	788.01	749.83	697.21	611.12	530.73	573.73

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	9.53	9.53	9.52	9.51	9.45	9.45
Additional Paid-In Capital	-	968.65	966.52	960.98	1,009	1,032
Retained Earnings	-	1,888	1,623	1,395	1,213	1,008
Comprehensive Income & Other	2,745	46.38	39	26.19	12.55	-18.46
Shareholders' Equity	2,754	2,913	2,638	2,392	2,244	2,032
Total Liabilities & Equity	3,542	3,663	3,335	3,003	2,774	2,605

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	12.93	86.43	99.39	84.2	38.78	41.56
Net Cash (Debt)	1,324	1,159	927.29	645.35	1,007	802.67
Net Cash Growth	-3.32%	24.99%	43.69%	-35.89%	25.42%	-8.52%
Net Cash Per Share	1.19	1.04	0.83	0.58	0.90	0.72
Filing Date Shares Outstanding	1,092	1,124	1,123	1,122	1,116	1,116
Total Common Shares Outstanding	1,092	1,124	1,123	1,122	1,116	1,116
Working Capital	1,873	2,042	1,582	1,477	1,629	1,445
Book Value Per Share	2.52	2.59	2.35	2.13	2.01	1.82
Tangible Book Value	2,558	2,718	2,441	2,191	2,045	1,819
Tangible Book Value Per Share	2.34	2.42	2.17	1.95	1.83	1.63
Land	-	72.72	72.72	72.72	72.72	21.41
Machinery	-	487.21	432.54	434.91	353.99	308.62
Construction In Progress	-	78.26	271.05	145.25	19.48	12.41
Leasehold Improvements	-	26.21	87.38	88.85	82.52	77.93

Data Source: S&P Global Market Intelligence Last updated: Aug 26, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 1, 2026

Data Sources Report a data error